AI Summary
This article discusses preclinical and clinical studies focused on using extracellular vesicles derived from mesenchymal stem cells for treating chronic wounds. The research likely explores the efficacy and safety of this treatment approach, potential mechanisms of action, and the feasibility of translating findings to clinical practice. This work is significant as it may provide valuable insights into developing novel therapies for chronic wounds, addressing a significant medical need.
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c01121